Aminoglycosides in Early Sepsis
Abroad (travel likely)RecruitingPHASE4
Conditions
Sepsis
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Haukeland University Hospital, Bergen, Bergen, Norway
Contact: Study coordinator (Oddvar Oppegaard, MD PhD) · oddvar.oppegaard@helse-bergen.no · +47 97 58 57 09Lovisenberg Diakonal Hospital, Oslo, Oslo, Norway
St. Olav's Hospital, Trondheim, Trondheim, Norway
Contact: Study coordinator (Birgitta Ehrnström, MD PhD) · birgitta.ehrnstrom@ntnu.no · +47 45 51 10 37Akershus University Hospital, Lørenskog, Norway
Contact: Study coordinator (Magnus N Lyngbakken, MD PhD) · magnus.lyngbakken@medisin.uio.no · +4793408837Contact: Principal Investigator (Magnus N Lyngbakken, MD PhD)Olav Dalgard, MD PhD (Sub-investigator)Jan Erik Berdal, MD PhD (Sub-investigator)Kristian N Malme, MD (Sub-investigator)Magrit J Hovind, MD (Sub-investigator)Oslo University Hospital Ullevål, Oslo, Norway
Contact: Study coordinator (Aleksander R Holten, MD PhD) · aleksander.holten@gmail.com · +4799275784Contact: Principal Investigator (Kristian Tonby, MD PhD)Aleksander R Holten, MD PhD (Sub-investigator)